Tekmira Pharmaceuticals Corp. has entered into a manufacturing and clinical trial agreement with the University of Oxford to provide the new TKM-Ebola-Guinea therapeutic product for clinical studies in West Africa, which are expected to begin early next year.   The University is the representative of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), which will conduct the clinical studies with funding provided by the Wellcome Trust. GMP manufacture of TKM-Ebo...